Page 10 - ப்ராஸ்டேட் புற்றுநோய் பரிசோதனை சந்தை அளவு பகுப்பாய்வு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ப்ராஸ்டேட் புற்றுநோய் பரிசோதனை சந்தை அளவு பகுப்பாய்வு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ப்ராஸ்டேட் புற்றுநோய் பரிசோதனை சந்தை அளவு பகுப்பாய்வு Today - Breaking & Trending Today

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug


Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug
Allarity Therapeutics of Hørsholm, Denmark, today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the British variant ), at the COVID-19 Testing Service Center (CTSC) of Northern Arizona University s Pathogen and Microbiome Institute (PMI), a leading U.S. infectious disease testing center.
The virus variant was labeled Variant of Concern 202012/01 by Public Health England (PHE), an agency of the UK Department of Health and Social Care, in a publication on December 21, 2020, after it was found to have spread rapidly within the UK, and the PHE assessed that this variant has a substantially increased transmissibility compared with other coronavirus variants. ....

United States , United Kingdom , Dana Farber Cancer Institute , Stever Carchedi , Paul Keim , Emily Henderson , Centers For Disease , Human Services , National Institutes Of Health , Northern Arizona University , Biomedical Advanced Research , Northern Arizona University Pathogen , Testing Service Center , Development Authority , Public Health England , Department Of Health , Microbiome Institute , United Kingdom Department Of Health , Service Center , United Kingdom Department , Social Care , Disease Control , Nathan Stone , Ribose Polymerase , Allarity Therapeutics , Todd French ,